A randomized clinical trial of photodynamic therapy with methyl aminolaevulinate vs. diclofenac 3% plus hyaluronic acid gel for the treatment of multiple actinic keratoses of the face and scalp

British Journal of Dermatology

Volumn 170, Issue 5, 2014, Pages 1143-1150

  Zane, C ^a   Facchinetti, E ^a   Rossi, M T ^a   Specchia, C ^a   Calzavara Pinton, P G ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID METHYL ESTER; DERMATOLOGICAL AGENT; DICLOFENAC; HYALURONIC ACID; METHYL AMINOLAEVULINATE; POLYURETHAN; UNCLASSIFIED DRUG; AMINOLEVULINIC ACID; DRUG COMBINATION; GEL; METHYL 5-AMINOLEVULINATE; PHOTOSENSITIZING AGENT;

ACTINIC KERATOSIS; ADULT; AGED; ARTICLE; BLISTER; BURNING SENSATION; CLINICAL PROTOCOL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG CLEARANCE; DRUG COST; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG ERUPTION; DRUG TOLERABILITY; EDEMA; ERYTHEMA; FACE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT SATISFACTION; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RETREATMENT; SCALP; TREATMENT DURATION; TREATMENT OUTCOME; ANALOGS AND DERIVATIVES; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; DRUG COMBINATION; ECONOMICS; FACIAL DERMATOSES; GEL; KERATOSIS, ACTINIC; MIDDLE AGED; PHOTOCHEMOTHERAPY; PROCEDURES; SCALP DERMATOSES; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AMINOLEVULINIC ACID; COST-BENEFIT ANALYSIS; DICLOFENAC; DRUG COMBINATIONS; FACIAL DERMATOSES; FEMALE; GELS; HUMANS; HYALURONIC ACID; KERATOSIS, ACTINIC; MALE; MIDDLE AGED; PATIENT SATISFACTION; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROSPECTIVE STUDIES; SCALP DERMATOSES; TREATMENT OUTCOME;

EID: 84901023971     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12844     Document Type: Article

References (26)

1. Neidecker MV, Davis-Ajami ML, Balkrishnan R, Feldman SR,. Pharmacoeconomic considerations in treating actinic keratosis. Pharmacoeconomics 2009; 27: 451-64.
2. Glogau RG,. Physiological and structural changes associated with ageing skin. Dermatol Clin 1997; 15: 555-9.
3. Stockfleth E, Ferrandiz C, Grob JJ, et al,. Development of a treatment algorithm for actinic keratoses: a European Consensus. Eur J Dermatol 2008; 18: 651-9.
4. de Berker D, McGregor JM, Hughes BR,; British Association of Dermatologists Therapy Guidelines Audit Subcommittee. Guidelines for the management of actinic keratoses. Br J Dermatol 2007; 156: 222-30.
5. Gupta AK, Paquet M, Villanueva E, Brintnell W,. Interventions for actinic keratoses. Cochrane Database Syst Rev 2012; (12): CD004415.
6. Olsen EA, Abernethy L, Kulp-Shorten C, et al,. A double-blind, vehicle-controlled study evaluating masoprocol cream in the treatment of actinic keratoses on the head and neck. J Am Acad Dermatol 1991; 24: 738-43.
7. Babilas P, Kohl E, Maisch T, et al,. In vitro and in vivo comparison of two different light sources for topical photodynamic therapy. Br J Dermatol 2006; 154: 712-18.
8. Colombo GL, Chimenti S, Di Matteo S, et al,. Cost-effectiveness analysis of topical treatments of actinic keratoses in the perspective of the Italian National Health System. G Ital Dermatol Venereol 2010; 145: 573-85.
9. Rossi R, Calzavara-Pinton PG, Giannetti A, et al,. Italian guidelines and therapeutic algorithm for actinic keratoses. G Ital Dermatol Venereol 2009; 144: 713-23.
10. Hanley JA, Negassa A, Edwardes MD, Forrester JE,. Statistical analysis of correlated data using generalized estimating equations: an orientation. Am J Epidemiol 2003; 157: 364-75.
11. Szeimies RM, Karrer S, Radakovic-Fijan S, et al,. Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: a prospective, randomized study. J Am Acad Dermatol 2002; 47: 258-62.
12. Morton C, Campbell S, Gupta G, et al,. Intraindividual, right-left comparison of topical methyl aminolaevulinate-photodynamic therapy and cryotherapy in subjects with actinic keratoses: a multicentre, randomized controlled study. Br J Dermatol 2006; 155: 1029-36.
13. Kaufmann R, Spelman L, Weightman W, et al,. Multicentre intraindividual randomized trial of topical methyl aminolaevulinate-photodynamic therapy vs. cryotherapy for multiple actinic keratoses on the extremities. Br J Dermatol 2008; 158: 994-9.
14. Pariser DM, Lowe NJ, Stewart DM, et al,. Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial. J Am Acad Dermatol 2003; 48: 227-32.
15. Freeman M, Vinciullo C, Francis D, et al,. A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study. J Dermatolog Treat 2003; 14: 99-106.
16. Rivers JK, McLean DI,. An open study to assess the efficacy and safety of topical 3% diclofenac in 2.5% hyaluronic acid gel in the treatment of actinic keratoses. Arch Dermatol 1997; 133: 1239-42.
17. Wolf JE Jr, Taylor JR, Tschen E, Kang S,. Topical 3.0% diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses. Int J Dermatol 2001; 40: 709-13.
18. Rivers JK, Arlette J, Shear N, et al,. Topical treatment of actinic keratoses with 3.0% diclofenac in 2.5% hyaluronan gel. Br J Dermatol 2002; 146: 94-100.
19. Gebauer K, Brown P, Varigos G,. Topical diclofenac in hyaluronan gel for the treatment of solar keratoses. Australas J Dermatol 2003; 44: 40-3.
20. Nelson C, Rigel D, Smith S, et al,. Phase IV, open-label assessment of the treatment of actinic keratosis with 3.0% diclofenac sodium topical gel (Solaraze). J Drugs Dermatol 2004; 3: 401-7.
21. Dirschka T, Bierhoff E, Pflugfelder A, Garbe C,. Topical 3.0% diclofenac in 2.5% hyaluronic acid gel induces regression of cancerous transformation in actinic keratoses. J Eur Acad Dermatol Venereol 2010; 24: 258-63.
22. Pflugfelder A, Welter AK, Leiter U, et al,. Open label randomized study comparing 3 months vs. 6 months treatment of actinic keratosis with 3% diclofenac in 2.5% hyaluronic acid gel: a trial of the German Dermatologic Cooperative Oncology Group. J Eur Acad Dermatol Venereol 2011; 26: 48-53.
23. McEwan LE, Smith JG,. Topical diclofenac/hyaluronic acid gel in the treatment of solar keratoses. Australas J Dermatol 1997; 38: 187-9.
24. Fariba I, Ali A, Hossein SA, et al,. Efficacy of 3% diclofenac gel for the treatment of actinic keratoses: a randomized, double-blind, placebo controlled study. Indian J Dermatol Venereol Leprol 2006; 72: 346-9.
25. Kose O, Koc E, Erbil AH, et al,. Comparison of the efficacy and tolerability of 3% diclofenac sodium gel and 5% imiquimod cream in the treatment of actinic keratosis. J Dermatolog Treat 2008; 19: 159-63.
26. Akarsu S, Aktan S, Atahan A, et al,. Comparison of topical 3% diclofenac sodium gel and 5% imiquimod cream for the treatment of actinic keratoses. Clin Exp Dermatol 2011; 36: 479-84.